Ropivacaine Hydrochloride Monohydrate (CAS 132112-35-7)
QUICK LINKS
Ropivacaine Hydrochloride Monohydrate is an anesthetic and analgesic compound. It functions primarily by blocking the voltage-gated sodium channels in the neuronal membrane, leading to a reversible inhibition of ion fluxes required for the initiation and conduction of impulses. This blockade effectively decreases the permeability of the neuronal membrane to sodium ions, which stabilizes the neuronal membrane and inhibits nerve impulse initiation and conduction. In research applications, Ropivacaine Hydrochloride Monohydrate is utilized to study the mechanisms underlying nerve blockade, pain transmission, and the modulation of synaptic transmission. It provides useful for dissecting the pharmacodynamics of local anesthetic action, exploring the molecular basis of its selectivity for sensory versus motor blockade, and understanding its differential effects on nerve fiber types. This compound′s distinct pharmacokinetic profile, characterized by its potency and duration of action, makes it particularly useful for investigations into the development of new anesthetics.
Ropivacaine Hydrochloride Monohydrate (CAS 132112-35-7) References
- The effects of ropivacaine hydrochloride on platelet function: an assessment using the platelet function analyser (PFA-100). | Porter, J., et al. 2001. Anaesthesia. 56: 15-8. PMID: 11167430
- Caudal blockade as alternative therapeutic approach in neonatal arterial thrombosis. | De Carolis, MP., et al. 2001. Eur J Pediatr. 160: 61-2. PMID: 11195023
- On the mechanism of drug release from oil suspensions in vitro using local anesthetics as model drug compounds. | Larsen, SW., et al. 2008. Eur J Pharm Sci. 34: 37-44. PMID: 18374550
- Peripheral blockade as treatment of arm ischaemia at birth. | De Carolis, MP., et al. 2010. Eur J Pediatr. 169: 1267-9. PMID: 20339869
- Outpatient inguinal hernia repair under local anaesthesia: feasibility and efficacy of ultrasound-guided transversus abdominis plane block. | Milone, M., et al. 2013. Hernia. 17: 749-55. PMID: 23160979
- Development of a method to measure free and bound ropivacaine in human plasma using equilibrium dialysis and hydrophilic interaction chromatography coupled to high resolution mass spectrometry. | Abbas, M., et al. 2013. Talanta. 117: 60-3. PMID: 24209310
- Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. | Lirk, P., et al. 2014. Br J Anaesth. 113 Suppl 1: i32-8. PMID: 24946779
- Disposition kinetics of ropivacaine in humans. | Lee, A., et al. 1989. Anesth Analg. 69: 736-8. PMID: 2589653
- Full Percutaneous Treatment of Degenerative Disc Disease with Intradiscal Lumbar Interbody Fusion and Posterior Stabilization: Preliminary Results. | Fiori, R., et al. 2020. Cardiovasc Intervent Radiol. 43: 889-896. PMID: 32342158
- Determination of free concentration of ropivacaine and bupivacaine in blood plasma by ultrafiltration and coupled-column liquid chromatography. | Arvidsson, T. and Eklund, E. 1995. J Chromatogr B Biomed Appl. 668: 91-8. PMID: 7550986
- Lack of metabolic racemisation of ropivacaine, determined by liquid chromatography using a chiral AGP column. | Arvidsson, T., et al. 1995. Chirality. 7: 272-7. PMID: 7640170
- Validation of a capillary electrophoresis method for the enantiomeric purity testing of ropivacaine, a new local anaesthetic compound. | Sänger-van de Griend, CE. and Gröningsson, K. 1996. J Pharm Biomed Anal. 14: 295-304. PMID: 8851754
- A chiral capillary electrophoresis method for ropivacaine hydrochloride in pharmaceutical formulations: validation and comparison with chiral liquid chromatography. | Sänger-van de Griend, CE., et al. 1997. J Pharm Biomed Anal. 15: 1051-61. PMID: 9215957
- Mitochondrial effects of L-ropivacaine, a new local anesthetic. | Scutari, G., et al. 1998. Biochem Pharmacol. 56: 1633-7. PMID: 9973184
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Ropivacaine Hydrochloride Monohydrate, 10 mg | sc-208314 | 10 mg | $84.00 | |||
Ropivacaine Hydrochloride Monohydrate, 100 mg | sc-208314A | 100 mg | $408.00 |